Quest Diagnostics Incorporated (LON:0KSX)
179.20
-0.99 (-0.55%)
At close: Jun 18, 2025
Quest Diagnostics Revenue
Quest Diagnostics had revenue of $2.65B USD in the quarter ending March 31, 2025, with 12.09% growth. This brings the company's revenue in the last twelve months to $10.16B, up 9.38% year-over-year. In the year 2024, Quest Diagnostics had annual revenue of $9.87B with 6.70% growth.
Revenue (ttm)
$10.16B
Revenue Growth
+9.38%
P/S Ratio
1.89
Revenue / Employee
$181.39K
Employees
56,000
Market Cap
14.87B GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 9.87B | 620.00M | 6.70% |
Dec 31, 2023 | 9.25B | -631.00M | -6.38% |
Dec 31, 2022 | 9.88B | -905.00M | -8.39% |
Dec 31, 2021 | 10.79B | 1.35B | 14.32% |
Dec 31, 2020 | 9.44B | 1.71B | 22.15% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 42.56B |
GSK plc | 31.53B |
Haleon | 11.23B |
Smith & Nephew | 4.64B |
ConvaTec Group | 1.83B |
Hikma Pharmaceuticals | 2.50B |
HUTCHMED (China) | 503.39M |
Indivior | 905.57M |
Quest Diagnostics News
- 10 days ago - Quest Diagnostics to Develop Multi-cancer Stratification (MCaST) Blood Test Based on MD Anderson Technology - PRNewsWire
- 21 days ago - Here's How Much You Would Have Made Owning Quest Diagnostics Stock In The Last 5 Years - Benzinga
- 4 weeks ago - More Americans Know Their Streaming Platform Passwords by Heart Than Their Cholesterol Score, New Survey Reveals - PRNewsWire
- 5 weeks ago - $1000 Invested In This Stock 5 Years Ago Would Be Worth This Much Today - Benzinga
- 5 weeks ago - Quest Diagnostics to Speak at the William Blair 45th Annual Growth Stock Conference - PRNewsWire
- 5 weeks ago - Quest Diagnostics declares $0.80 dividend - Seeking Alpha
- 5 weeks ago - Quest Diagnostics Declares Quarterly Cash Dividend - PRNewsWire
- 5 weeks ago - Oncologists Report Seeing More Advanced Cancers and Say Current Tests Are Not Catching Cancer Recurrence Early Enough, New Quest Diagnostics Report Finds - PRNewsWire